학술논문

International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20-Positive B Cell PTLD: Clues From the PTLD-1 Trial
Document Type
Article
Source
In American Journal of Transplantation April 2015 15(4):1091-1100
Subject
Language
ISSN
1600-6135

Online Access